Variant report
Variant | esv2762715 |
---|---|
Chromosome Location | chr8:3904034-3904730 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3906471 | chr8:3904034-3904035 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs374947489 | chr8:3904037-3904038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543941280 | chr8:3904040-3904041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs147412284 | chr8:3904048-3904049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529872713 | chr8:3904073-3904074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547997459 | chr8:3904086-3904087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2740898 | chr8:3904088-3904089 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs185557875 | chr8:3904114-3904115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs80229201 | chr8:3904122-3904123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs75737456 | chr8:3904126-3904127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569227054 | chr8:3904130-3904131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs375429792 | chr8:3904132-3904133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200169147 | chr8:3904134-3904135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558468851 | chr8:3904145-3904146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570470441 | chr8:3904146-3904147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370644077 | chr8:3904154-3904155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150498113 | chr8:3904162-3904163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573185948 | chr8:3904169-3904170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79943222 | chr8:3904178-3904179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs3849817 | chr8:3904188-3904189 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs3849818 | chr8:3904192-3904193 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs554407776 | chr8:3904217-3904218 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566334107 | chr8:3904226-3904227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76915327 | chr8:3904228-3904229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139463738 | chr8:3904232-3904233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576410224 | chr8:3904242-3904243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs3860860 | chr8:3904248-3904249 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs555407424 | chr8:3904258-3904259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540454343 | chr8:3904260-3904261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573818420 | chr8:3904272-3904273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs5002849 | chr8:3904283-3904284 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs368643406 | chr8:3904289-3904290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559927042 | chr8:3904290-3904291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77495108 | chr8:3904299-3904300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143238057 | chr8:3904300-3904301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563907214 | chr8:3904301-3904302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs3849819 | chr8:3904302-3904303 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs189562332 | chr8:3904310-3904311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568113270 | chr8:3904320-3904321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181537133 | chr8:3904328-3904329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546265484 | chr8:3904339-3904340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs367685959 | chr8:3904345-3904346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78856481 | chr8:3904346-3904347 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539721404 | chr8:3904350-3904351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146691309 | chr8:3904360-3904361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570269075 | chr8:3904361-3904362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543818062 | chr8:3904391-3904392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371706743 | chr8:3904395-3904396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377169288 | chr8:3904401-3904402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140304972 | chr8:3904405-3904406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3889600-3904400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr8:3897400-3904200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr8:3902600-3904800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr8:3904200-3904800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr8:3904200-3905000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr8:3904200-3905000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr8:3904400-3904800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |